Vertex Ventures China was adamant that Neiwai should expand offline on leading a Series B for the lingerie brand in 2017. Four years and two rounds later, the strategy is paying off
Neiwai’s $100 million Series D round – led by The Carlyle Group with participation from Vertex Ventures China and Qiming Venture Partners – comes two years after the Series C. Much has changed in...
Semiconductors are a popular investment target in China on the back of US decoupling and a push for self-sufficiency. Alex Banh, a managing partner of sector specialist IPV Capital, shares his views
China has imposed severe restrictions on private tutoring that appear to undermine the commercial viability of companies in the space, potentially making private equity investment unviable.
Best & Less Group (BLG), an Australian baby, kids and womenswear retailer, has raised A$60 million ($44 million) through a domestic IPO, facilitating a partial exit for majority owner Allegro Funds Group.
TransThera, a China-based drug developer, has raised $100 million in Series D funding led by CPE and China Structural Reform Fund.